ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1873

Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale

Nilamba Jhala1, Yaseen Kinanah2, Sahar Kaouk3, Deb Bork4, Sara Davin5, Sarah Rispinto5, William Wilke4 and Carmen E. Gota4, 1Internal Medicine, Cleveland Clinic, Cleveland, OH, 2Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 3John Carroll University, University Heights, OH, 4Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 5Neurologic Institute, Cleveland Clinic, Cleveland, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Both the fibromyalgia impact questionnaire (FIQ) and the polysymptomatic distress scale (PSD) have been proposed as measures of FM impact and severity. It is not known how they related to each other and to what extent they relate to FM process items such as pain, depression, anxiety, and catastrophizing.

We set to compare the correlation between FIQ and PSD, and their correlates with depression, anxiety, and catastrophizing, and to determine the individual impact of FIQ and PSD on pain disability index as a measure of the extent to which fibromyalgia pain interferes with a patient’s ability to engage in essential life activities. In this study we considered pain disability index as a surrogate for FM severity.

Methods:

The PSD is the sum of two variables used in the 2010 preliminary American College of Rheumatology fibromyalgia criteria, the widespread pain index (WPI) and symptom severity scale (SS). The FiQ, captures the total spectrum of problems related to FM and has been used as a measure of fibromyalgia severity.

The pain disability index measures the impact of chronic pain on seven essential life activities, family, recreational, social, occupational, sexual, self care, and life support. and is the sum of the scores (0 – 10) of all life activities divided by the number of activities rated. We measured the patient health questionnaire (PHQ-9) for depression, the general anxiety disorder scale (GAD-7), and the pain catastrophizing scale.

Results:

Patients diagnosed clinically with FM were included:n 555, 85.5% female, 79.5% white, age 44.3 (12), 87.2% met ACR 2010 FM criteria, PHQ-9 13.7 (6.5), GAD-7 8.6 (6.6), pain catastrophizing scale 22.6 (13.4), PSD 21 (10.6), FIQ 57.9 (20.4), pain disability index 5.3 (2.3).

FIQ correlated with PSD r 0.465, GAD-7 r 0.368, PHQ-9 r 0.476, pain catastrophizing scale r 0.416, pain disability index r 0.602; PSD score correlated with GAD-7 r 0.233, PHQ-9 r 0.371, pain catastrophizing scale r 0.262, pain disability index r 0.377. All correlations were significant at p<0.001.

Linear regression was calculated to predict FIQ based on GAD-7, PHQ-9 and pain catastrophizing scale. A significant regression equation was found F(1, 120)=42.064, P<0.001, R2 0.513 of FIQ. Depression and catastrophizing scores remaining independent predictors of FIQ. A similar model significantly predicts the PSD score, F(1,130)=26.849, P<0.001, R2 0.383 of PSD; only depression measured by PHQ-9 remained an independent predictor of PSD. To measure the individual contribution of FIQ and PSD score on pain disability index we performed a linear regression model. A significant regression equation was found F(2,165)=154.619, R2 0f 0.652 of PDI. In this model, FIQ but not PSD remained independent predictor of pain disability index.

Conclusion:

Our data suggests that the FIQ and the PSD show only a moderate degree of correlation. Also, the FIQ has stronger associations with FM process measures including depression, anxiety, pain catastrophizing and pain disability index, compared to the PSD. This may explain why the FIQ, but not the PSD remains an independent predictor of pain disability score.


Disclosure: N. Jhala, None; Y. Kinanah, None; S. Kaouk, None; D. Bork, None; S. Davin, None; S. Rispinto, None; W. Wilke, None; C. E. Gota, None.

To cite this abstract in AMA style:

Jhala N, Kinanah Y, Kaouk S, Bork D, Davin S, Rispinto S, Wilke W, Gota CE. Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/evaluating-pain-related-disability-in-fibromyalgia-a-comparison-of-the-fibromyalgia-impact-questionnaire-and-the-polysymptomatic-distress-scale/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-pain-related-disability-in-fibromyalgia-a-comparison-of-the-fibromyalgia-impact-questionnaire-and-the-polysymptomatic-distress-scale/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology